The Role of Endothelin in Pulmonary Hypertension

Completed · Phase 2

Conditions studied: Pulmonary Hypertension

In brief

The purpose of the study is is to determine the effect, on the lung circulation, of BQ-123, an investigational compound which is not approved by the FDA.

Key facts

Study ID

NCT00759408

Run by

Brigham and Women's Hospital

People needed

38

Starts

1999-02-01

Expected to finish

2011-06-01

Last updated by the study team

2018-11-27

Who can join

Age: 18 and older, up to 85. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Healthy volunteers or known diagnosis of pulmonary hypertension

You may not qualify if…

• hypertension due to other reasons (not pulmonary)

Where it is running

• Brigham and Women's Hospital — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.